Literature DB >> 6773985

Lysine fluxes across the jejunal epithelium in lysinuric protein intolerance.

J F Desjeux, R O Simell, A M Dumontier, J Perheentupa.   

Abstract

Lysinuric protein intolerance (LPI) is one of a group of genetic diseases in which intestinal absorption of the diamino acids lysine, arginine, and ornithine is impaired. In LPI, the clinical symptoms are more severe than in the kindred disorders. The mechanism of lysine absorption was, therefore, investigated in vitro on peroral jejunal biopsy specimens in seven patients with LPI and 27 controls. The lysine concentration ratio between cell compartment and medium was significantly higher in the LPI group (mean+/-SEM, 7.17+/-0.60) than in the controls (5.44+/-0.51). This was also true for the intracellular Na concentration (LPI, 73.6+/-10.8 mM; controls 42.3+/-3.7 mM). The rate of unidirectional influx of lysine across the luminal membrane was Na dependent and was the same in the two groups. In the absence of an electrochemical gradient, net transepithelial lysine secretion was observed in LPI. This was entirely the result of a 60% reduction of the unidirectional flux from mucosa to serosa. Calculation of unidirectional fluxes revealed the most striking difference at the basolateral membrane, where the flux from cells to serosa was reduced by 62% and the corresponding permeability coefficient reduced by 71%. A progressive reduction in short-circuit current appeared in the epithelia of all four patients with LPI tested after addition of 3 mM lysine. Thus, LPI appears to be the first disease in which a genetically determined transport defect has been demonstrated at the basolateral membrane.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6773985      PMCID: PMC371476          DOI: 10.1172/JCI109802

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  A SIMPLIFIED GASTROINTESTINAL BIOPSY CAPSULE.

Authors:  J B CAREY
Journal:  Gastroenterology       Date:  1964-05       Impact factor: 22.682

2.  Intestinal depeptide transport in normal and cystinuric subjects.

Authors:  M D Hellier; C D Holdsworth; D Perrett; C Thirumalai
Journal:  Clin Sci       Date:  1972-11       Impact factor: 6.124

3.  Hyperlysinuria with hyperammonemia. A new metabolic disorder.

Authors:  J H Brown; L F Fabre; G L Farrell; E D Adams
Journal:  Am J Dis Child       Date:  1972-07

4.  Hyperdibasicaminoaciduria: an inherited disorder of amino acid transport.

Authors:  D T Whelan; C R Scriver
Journal:  Pediatr Res       Date:  1968-11       Impact factor: 3.756

5.  Electrical potential profile in rabbit ileum: role of rheogenic Na transport.

Authors:  R C Rose; D L Nahrwold; M J Koch
Journal:  Am J Physiol       Date:  1977-01

6.  The mechanism of hyperammonemia in congenital lysinuria.

Authors:  K Oyanagi; H Sogawa; R Minami; T Nakao; T Chiba
Journal:  J Pediatr       Date:  1979-02       Impact factor: 4.406

7.  Hyperdibasicaminoaciduria in a mentally retarded homozygote with a peculiar response to phenothiazines.

Authors:  H Kihara; M Valente; M T Porter; A L Fluharty
Journal:  Pediatrics       Date:  1973-02       Impact factor: 7.124

8.  Hyperdibasicaminoaciduria, hyperammonemia, and growth retardation: Treatment with arginine, lysine, and citrulline.

Authors:  A E Awrich; W J Stackhouse; J E Cantrell; J H Patterson; D Rudman
Journal:  J Pediatr       Date:  1975-11       Impact factor: 4.406

9.  Renal handling of diamino acids in lysinuric protein intolerance.

Authors:  O Simell; J Perheentupa
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

10.  Alanine efflux across the serosal border of turtle intestine.

Authors:  J J Hajjar; R N Khuri; P F Curran
Journal:  J Gen Physiol       Date:  1972-12       Impact factor: 4.086

View more
  12 in total

1.  The molecular and genetic base of congenital transport defects.

Authors:  J F Desjeux
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

2.  Expression of heteromeric amino acid transporters along the murine intestine.

Authors:  Mital H Dave; Nicole Schulz; Marija Zecevic; Carsten A Wagner; Francois Verrey
Journal:  J Physiol       Date:  2004-05-21       Impact factor: 5.182

3.  Metabolism of citrulline in man.

Authors:  D Rabier; P Kamoun
Journal:  Amino Acids       Date:  1995-12       Impact factor: 3.520

4.  Lysinuric protein intolerance (LPI) gene maps to the long arm of chromosome 14.

Authors:  T Lauteala; P Sistonen; M L Savontaus; J Mykkänen; J Simell; M Lukkarinen; O Simell; P Aula
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

5.  Lysinuric protein intolerance mutation is not expressed in the plasma membrane of erythrocytes.

Authors:  D W Smith; C R Scriver; O Simell
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

6.  Absorptive transport of amino acids by the rat colon.

Authors:  Yuxin Chen; Meredith M Dinges; Andrew Green; Scott E Cramer; Cynthia K Larive; Christian Lytle
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-25       Impact factor: 4.052

7.  Dibasic amino acid transport: lessons from human disease.

Authors:  S O Thier
Journal:  Trans Am Clin Climatol Assoc       Date:  1984

8.  Renal transport of lysine and arginine in lysinuric protein intolerance.

Authors:  T Kato; N Mizutani; M Ban
Journal:  Eur J Pediatr       Date:  1982-11       Impact factor: 3.183

9.  Lysinuric protein intolerance mutation is expressed in the plasma membrane of cultured skin fibroblasts.

Authors:  D W Smith; C R Scriver; H S Tenenhouse; O Simell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

10.  First reported case of lysinuric protein intolerance (LPI) in Lithuania, confirmed biochemically and by DNA analysis.

Authors:  Loreta Cimbalistiene; Willy Lehnert; Kirsi Huoponen; Vaidutis Kucinskas
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.